These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 25644677)

  • 21. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
    Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
    Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
    Eriksson P
    J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ANCA-associated forms of vasculitis].
    Helmchen U; Kneissler U; Prall F
    Verh Dtsch Ges Pathol; 1996; 80():38-45. PubMed ID: 9065053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulomatosis with polyangiitis and intravenous immunoglobulins: a case series and review of the literature.
    Guidelli GM; Tenti S; Pascarelli NA; Galeazzi M; Fioravanti A
    Autoimmun Rev; 2015 Aug; 14(8):659-64. PubMed ID: 25816995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.
    Lynch JP; Derhovanessian A; Tazelaar H; Belperio JA
    Semin Respir Crit Care Med; 2018 Aug; 39(4):434-458. PubMed ID: 30404111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy.
    Specks U; Fervenza FC; McDonald TJ; Hogan MC
    Arthritis Rheum; 2001 Dec; 44(12):2836-40. PubMed ID: 11762944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.
    Omdal R; Wildhagen K; Hansen T; Gunnarsson R; Kristoffersen G
    Scand J Rheumatol; 2005; 34(3):229-32. PubMed ID: 16134730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Wegener's granulomatosis--diagnostic problem].
    Durko T; Lapienis M; Jankowski A
    Otolaryngol Pol; 2006; 60(3):355-62. PubMed ID: 16989448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical manifestations and treatment of Wegener's granulomatosis.
    Holle JU; Laudien M; Gross WL
    Rheum Dis Clin North Am; 2010 Aug; 36(3):507-26. PubMed ID: 20688247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Granulomatosis with polyangiitis - clinical picture and review of current treatment options].
    Lembicz M; Batura-Gabryel H; Nowicka A
    Pneumonol Alergol Pol; 2014; 82(1):61-73. PubMed ID: 24391073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in pathogenesis and treatment of ANCA-associated vasculitis.
    Kallenberg CG
    Discov Med; 2014 Oct; 18(99):195-201. PubMed ID: 25336033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal & ocular targets for therapy in Wegener's granulomatosis.
    Joshi L; Hamour S; Salama AD; Pusey CD; Lightman S; Taylor SR
    Inflamm Allergy Drug Targets; 2009 Mar; 8(1):70-9. PubMed ID: 19275695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis.
    Langford CA
    Clin Exp Immunol; 2011 May; 164 Suppl 1(Suppl 1):31-4. PubMed ID: 21447129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the therapy of Wegener's granulomatosis.
    Hellmich B; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2006 Jan; 18(1):25-32. PubMed ID: 16344616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower doses of rituximab in remission induction for refractory granulomatosis with polyangiitis.
    Wawrzycka-Adamczyk K; Zugaj A; Włudarczyk A; Kosałka J; Sznajd J; Bazan-Socha S; Musiał J
    Przegl Lek; 2014; 71(12):663-5. PubMed ID: 25951692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
    Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
    Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
    [No Abstract]   [Full Text] [Related]  

  • 37. Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.
    Tektonidou MG; Skopouli FN
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S103. PubMed ID: 16859607
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement.
    Roccatello D; Baldovino S; Alpa M; Rossi D; Napoli F; Naretto C; Cavallo R; Giachino O
    Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S67-71. PubMed ID: 18799057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current Understanding and Unknown Aspects of the Treatment of Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Opportunities for Future Studies.
    Alesaeidi S; Darvishi M; Dabiri S; GhasemiAdl M; Jafarieh A; Tavakolpour S
    Curr Rheumatol Rev; 2020; 16(4):257-266. PubMed ID: 32228425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Granulomatosis with polyangiitis (Wegener's granulomatosis)].
    Karras A; Guiard E; Lévi C; Thervet E
    Presse Med; 2012 Oct; 41(10):1014-23. PubMed ID: 22902722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.